TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Clinical Relevance of Nevirapine Resistance
Brief Summary: This study is designed to test if a sequential protease-inhibitor (PI) - / nevirapine (NVP) -based regimen is effective for the treatment of HIV-infected children when previous NVP exposure has occurred as part of programs to prevent mother-to-child transmission (pMTCT).


Options:
A: Intervention Type: DRUG; Name: Lopinavir/Ritonavir; Assigned to Arm(s): N/A
B: Arm Label: Deferred therapy Arm; Type: EXPERIMENTAL; Interventions: Drug: Abacavir sulfate, Drug: Didanosine, Drug: Efavirenz, Drug: Lamivudine, Drug: Lopinavir/Ritonavir, Drug: Nevirapine, Drug: Zidovudine | Arm Label: Early therapy for 40 weeks; Type: EXPERIMENTAL; Interventions: Drug: Abacavir sulfate, Drug: Didanosine, Drug: Efavirenz, Drug: Lamivudine, Drug: Lopinavir/Ritonavir, Drug: Nevirapine, Drug: Zidovudine | Arm Label: Early therapy for 96 weeks; Type: EXPERIMENTAL; Interventions: Drug: Abacavir sulfate, Drug: Didanosine, Drug: Efavirenz, Drug: Lamivudine, Drug: Lopinavir/Ritonavir, Drug: Nevirapine, Drug: Zidovudine | Intervention Type: DRUG; Name: Abacavir sulfate; Assigned to Arm(s): Deferred therapy Arm, Early therapy for 40 weeks, Early therapy for 96 weeks | Intervention Type: DRUG; Name: Didanosine; Assigned to Arm(s): Deferred therapy Arm, Early therapy for 40 weeks, Early therapy for 96 weeks | Intervention Type: DRUG; Name: Efavirenz; Assigned to Arm(s): Deferred therapy Arm, Early therapy for 40 weeks, Early therapy for 96 weeks | Intervention Type: DRUG; Name: Lamivudine; Assigned to Arm(s): Deferred therapy Arm, Early therapy for 40 weeks, Early therapy for 96 weeks | Intervention Type: DRUG; Name: Lopinavir/Ritonavir; Assigned to Arm(s): Deferred therapy Arm, Early therapy for 40 weeks, Early therapy for 96 weeks | Intervention Type: DRUG; Name: Nevirapine; Assigned to Arm(s): Deferred therapy Arm, Early therapy for 40 weeks, Early therapy for 96 weeks | Intervention Type: DRUG; Name: Zidovudine; Assigned to Arm(s): Deferred therapy Arm, Early therapy for 40 weeks, Early therapy for 96 weeks
C: Arm Label: maternal nevirapine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nevirapine | Arm Label: maternal placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: No intervention | Intervention Type: DRUG; Name: Nevirapine; Assigned to Arm(s): maternal nevirapine | Intervention Type: DRUG; Name: No intervention; Assigned to Arm(s): maternal placebo
D: Intervention Type: DRUG; Name: nevirapine; Assigned to Arm(s): N/A

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prophylactic Cognitive Therapy for Depression.
Brief Summary: This study determined the effectiveness of continuation phase cognitive therapy versus antidepressant medication in preventing relapse of depression in people with recurrent depression.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Continuation phase cognitive therapy, Behavioral: Acute phase cognitive therapy | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Other: Continuation phase pill placebo, Behavioral: Acute phase cognitive therapy | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Drug: Continuation phase fluoxetine, Behavioral: Acute phase cognitive therapy | Intervention Type: BEHAVIORAL; Name: Continuation phase cognitive therapy; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Continuation phase fluoxetine; Assigned to Arm(s): 3 | Intervention Type: OTHER; Name: Continuation phase pill placebo; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Acute phase cognitive therapy; Assigned to Arm(s): 1, 2, 3
B: Arm Label: Mindfulness-based Cognitive Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness-based Cognitive Therapy, Biological: Standard psychiatric care | Arm Label: CBASP; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: The Cognitive Behavioral Analysis System of Psychotherapy, Biological: Standard psychiatric care | Arm Label: Treatment-as-usual; Type: ACTIVE_COMPARATOR; Interventions: Biological: Standard psychiatric care | Intervention Type: BEHAVIORAL; Name: Mindfulness-based Cognitive Therapy; Assigned to Arm(s): Mindfulness-based Cognitive Therapy | Intervention Type: BEHAVIORAL; Name: The Cognitive Behavioral Analysis System of Psychotherapy; Assigned to Arm(s): CBASP | Intervention Type: BIOLOGICAL; Name: Standard psychiatric care; Assigned to Arm(s): CBASP, Mindfulness-based Cognitive Therapy, Treatment-as-usual
C: Intervention Type: DRUG; Name: Venlafaxine ER; Assigned to Arm(s): N/A
D: Arm Label: CBASP; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Analysis System of Psychotherapy | Arm Label: SYSP; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: System of Supportive Psychotherapy | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Analysis System of Psychotherapy; Assigned to Arm(s): CBASP | Intervention Type: BEHAVIORAL; Name: System of Supportive Psychotherapy; Assigned to Arm(s): SYSP

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Stepped Care for Affective Disorders and Musculoskeletal Pain
Brief Summary: This study will evaluate the effectiveness of a stepped care approach in treating depression and reducing pain.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavior Therapy for Pain (CBT-P) | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Mindfulness Meditation for Emotion Regulation (MM-ER) | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: Rheumatoid arthritis education | Intervention Type: BEHAVIORAL; Name: Cognitive Behavior Therapy for Pain (CBT-P); Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Mindfulness Meditation for Emotion Regulation (MM-ER); Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: Rheumatoid arthritis education; Assigned to Arm(s): 3
B: Intervention Type: BEHAVIORAL; Name: self-management program; Assigned to Arm(s): N/A
C: Arm Label: Stepped Care; Type: EXPERIMENTAL; Interventions: Behavioral: Stepped Care, Drug: Antidepressants | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Drug: Usual Care | Arm Label: No Treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Stepped Care; Assigned to Arm(s): Stepped Care | Intervention Type: DRUG; Name: Antidepressants; Assigned to Arm(s): Stepped Care | Intervention Type: DRUG; Name: Usual Care; Assigned to Arm(s): Usual Care
D: Intervention Type: PROCEDURE; Name: Mod. functional restoration-Individ. dynamic back-muscle; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Stepped Care for Affective Disorders and Musculoskeletal Pain
Brief Summary: This study will evaluate the effectiveness of a stepped care approach in treating depression and reducing pain.


Options:
A: Arm Label: Treatment as usual; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Culturally focused psychiatric consultation; Type: EXPERIMENTAL; Interventions: Behavioral: Culturally focused psychiatric consultation | Intervention Type: BEHAVIORAL; Name: Culturally focused psychiatric consultation; Assigned to Arm(s): Culturally focused psychiatric consultation
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Other: Depression care management by secure messaging | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Depression care management by secure messaging; Assigned to Arm(s): 1
C: Arm Label: Stepped Care; Type: EXPERIMENTAL; Interventions: Behavioral: Stepped Care, Drug: Antidepressants | Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Drug: Usual Care | Arm Label: No Treatment; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Stepped Care; Assigned to Arm(s): Stepped Care | Intervention Type: DRUG; Name: Antidepressants; Assigned to Arm(s): Stepped Care | Intervention Type: DRUG; Name: Usual Care; Assigned to Arm(s): Usual Care
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: telephone depression care management | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: telephone depression care management; Assigned to Arm(s): 1

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)
Brief Summary: The purpose of this study is to evaluate the effectiveness of once weekly risedronate in the prevention and treatment of bone loss in premenopausal and newly menopausal women with breast cancer who have received chemotherapy.

The hypothesis is that bisphosphonate therapy will prevent bone loss at clinically relevant sites, such as the hip and spine. The investigators also hypothesize that there will be a correlation between biochemical markers of bone turnover and changes in bone mineral density.


Options:
A: Arm Label: A; Type: PLACEBO_COMPARATOR; Interventions: Drug: risedronate (including placebo) | Intervention Type: DRUG; Name: risedronate (including placebo); Assigned to Arm(s): A
B: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: 5-FU, Epirubicin, Cyclophosphamide, Docetaxel | Arm Label: B; Type: EXPERIMENTAL; Interventions: Drug: 5-FU, Epirubicin, Cyclophosphamide, Docetaxel, Zoledronic acid | Intervention Type: DRUG; Name: 5-FU, Epirubicin, Cyclophosphamide, Docetaxel; Assigned to Arm(s): A | Intervention Type: DRUG; Name: 5-FU, Epirubicin, Cyclophosphamide, Docetaxel, Zoledronic acid; Assigned to Arm(s): B
C: Arm Label: Pamidronate and placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pamidronate, Drug: placebo | Arm Label: Zoledronic acid and placebo; Type: ACTIVE_COMPARATOR; Interventions: Drug: Zoledronic acid, Drug: placebo | Intervention Type: DRUG; Name: Pamidronate; Assigned to Arm(s): Pamidronate and placebo | Intervention Type: DRUG; Name: Zoledronic acid; Assigned to Arm(s): Zoledronic acid and placebo | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Pamidronate and placebo, Zoledronic acid and placebo
D: Arm Label: Zometa; Type: EXPERIMENTAL; Interventions: Drug: Zometa, Drug: Epirubicin, Drug: Docetaxel, Drug: Trastuzumab, Radiation: External beam radiation, Procedure: Modified radical mastectomy or breast conserving surgery with axillary lymph node dissection | Arm Label: No Zometa; Type: ACTIVE_COMPARATOR; Interventions: Drug: Epirubicin, Drug: Docetaxel, Drug: Trastuzumab, Radiation: External beam radiation, Procedure: Modified radical mastectomy or breast conserving surgery with axillary lymph node dissection | Intervention Type: DRUG; Name: Zometa; Assigned to Arm(s): Zometa | Intervention Type: DRUG; Name: Epirubicin; Assigned to Arm(s): No Zometa, Zometa | Intervention Type: DRUG; Name: Docetaxel; Assigned to Arm(s): No Zometa, Zometa | Intervention Type: DRUG; Name: Trastuzumab; Assigned to Arm(s): No Zometa, Zometa | Intervention Type: RADIATION; Name: External beam radiation; Assigned to Arm(s): No Zometa, Zometa | Intervention Type: PROCEDURE; Name: Modified radical mastectomy or breast conserving surgery with axillary lymph node dissection; Assigned to Arm(s): No Zometa, Zometa

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: CSP #519 - Integrating Practice Guidelines for Smoking Cessation Into Mental Health Care for PTSD (SCP)
Brief Summary: The primary study objective is to conduct a prospective, randomized controlled clinical trial that compares the effectiveness of two approaches for delivering smoking cessation treatment for veterans with posttraumatic stress disorder (PTSD). An approach where smoking cessation treatment is integrated into mental health care for PTSD and delivered by mental health providers (experimental condition) will be compared to specialized smoking cessation clinic referral (VA's usual standard of care).

Secondary study objectives are to (a) compare the cost outcomes and cost-effectiveness of IC versus USC, (b) identify treatment process variables that explain (mediate) observed differences in smoking abstinence rates for the two study conditions, and (c) determine whether cessation from smoking is associated with worsening of symptoms of PTSD and/or depression.


Options:
A: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated Care for Smoking Cessation in PTSD patients | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard of Care | Intervention Type: BEHAVIORAL; Name: Integrated Care for Smoking Cessation in PTSD patients; Assigned to Arm(s): Arm 1 | Intervention Type: BEHAVIORAL; Name: Standard of Care; Assigned to Arm(s): Arm 2
B: Arm Label: Control (Usual care); Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Tobacco Cessation Tool (CATI Tool); Type: EXPERIMENTAL; Interventions: Behavioral: CATI Tool | Intervention Type: BEHAVIORAL; Name: CATI Tool; Assigned to Arm(s): Tobacco Cessation Tool (CATI Tool)
C: Intervention Type: BEHAVIORAL; Name: smoking cessation intervention; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: cancer prevention; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: counseling intervention; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: educational intervention; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: laboratory biomarker analysis; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: questionnaire administration; Assigned to Arm(s): N/A | Intervention Type: OTHER; Name: survey administration; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: study of high risk factors; Assigned to Arm(s): N/A
D: Intervention Type: BEHAVIORAL; Name: Advice; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Nicotine Gum and Patch; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Bupropion; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Clinical Trial Comparing Surveillance and Selective Surgical Treatment for Abdominal Aortic Aneurysms Less Than 5.5 cm in Diameter Versus Early Endovascular Treatment
Brief Summary: Objective of the present study is to compare endovascular repair versus surveillance and, eventually delay treatment in patients with small abdominal aortic aneurysms (AAA), with respect to patient survival, AAA rupture and AAA related death risks.


Options:
A: Arm Label: EVAR; Type: EXPERIMENTAL; Interventions: Procedure: EVAR (Endovascular repair of Abdominal Aortic aneurysm) | Arm Label: Surveillance; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Surveillance | Intervention Type: PROCEDURE; Name: EVAR (Endovascular repair of Abdominal Aortic aneurysm); Assigned to Arm(s): EVAR | Intervention Type: PROCEDURE; Name: Surveillance; Assigned to Arm(s): Surveillance
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Open repair | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Endovascular repair (with endograft) | Intervention Type: PROCEDURE; Name: Endovascular repair (with endograft); Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: Open repair; Assigned to Arm(s): 1
C: Arm Label: Surveillance; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Early Endovascular Repair; Type: EXPERIMENTAL; Interventions: Device: AneuRx AAA stent graft / Talent AAA stent graft | Intervention Type: DEVICE; Name: AneuRx AAA stent graft / Talent AAA stent graft; Assigned to Arm(s): Early Endovascular Repair
D: Arm Label: Arm 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard Open Repair | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Endovascular Repair | Intervention Type: PROCEDURE; Name: Endovascular Repair; Assigned to Arm(s): Arm 2 | Intervention Type: PROCEDURE; Name: Standard Open Repair; Assigned to Arm(s): Arm 1

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Clinical Trial Comparing Surveillance and Selective Surgical Treatment for Abdominal Aortic Aneurysms Less Than 5.5 cm in Diameter Versus Early Endovascular Treatment
Brief Summary: Objective of the present study is to compare endovascular repair versus surveillance and, eventually delay treatment in patients with small abdominal aortic aneurysms (AAA), with respect to patient survival, AAA rupture and AAA related death risks.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Open repair | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Endovascular repair (with endograft) | Intervention Type: PROCEDURE; Name: Endovascular repair (with endograft); Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: Open repair; Assigned to Arm(s): 1
B: Arm Label: EVAR; Type: EXPERIMENTAL; Interventions: Procedure: EVAR (Endovascular repair of Abdominal Aortic aneurysm) | Arm Label: Surveillance; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Surveillance | Intervention Type: PROCEDURE; Name: EVAR (Endovascular repair of Abdominal Aortic aneurysm); Assigned to Arm(s): EVAR | Intervention Type: PROCEDURE; Name: Surveillance; Assigned to Arm(s): Surveillance
C: Arm Label: Arm 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard Open Repair | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Endovascular Repair | Intervention Type: PROCEDURE; Name: Endovascular Repair; Assigned to Arm(s): Arm 2 | Intervention Type: PROCEDURE; Name: Standard Open Repair; Assigned to Arm(s): Arm 1
D: Arm Label: OR; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Open Aneurysm Repair | Arm Label: EVAR; Type: EXPERIMENTAL; Interventions: Procedure: Endovascular Aneurysm Repair | Intervention Type: PROCEDURE; Name: Open Aneurysm Repair; Assigned to Arm(s): OR | Intervention Type: PROCEDURE; Name: Endovascular Aneurysm Repair; Assigned to Arm(s): EVAR

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Clinical Trial Comparing Surveillance and Selective Surgical Treatment for Abdominal Aortic Aneurysms Less Than 5.5 cm in Diameter Versus Early Endovascular Treatment
Brief Summary: Objective of the present study is to compare endovascular repair versus surveillance and, eventually delay treatment in patients with small abdominal aortic aneurysms (AAA), with respect to patient survival, AAA rupture and AAA related death risks.


Options:
A: Arm Label: OR; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Open Aneurysm Repair | Arm Label: EVAR; Type: EXPERIMENTAL; Interventions: Procedure: Endovascular Aneurysm Repair | Intervention Type: PROCEDURE; Name: Open Aneurysm Repair; Assigned to Arm(s): OR | Intervention Type: PROCEDURE; Name: Endovascular Aneurysm Repair; Assigned to Arm(s): EVAR
B: Arm Label: 1; Type: OTHER; Interventions: Procedure: Endovascular repair | Arm Label: 2; Type: OTHER; Interventions: Procedure: Endovascular repair | Intervention Type: PROCEDURE; Name: Endovascular repair; Assigned to Arm(s): 1, 2
C: Arm Label: EVAR; Type: EXPERIMENTAL; Interventions: Procedure: EVAR (Endovascular repair of Abdominal Aortic aneurysm) | Arm Label: Surveillance; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Surveillance | Intervention Type: PROCEDURE; Name: EVAR (Endovascular repair of Abdominal Aortic aneurysm); Assigned to Arm(s): EVAR | Intervention Type: PROCEDURE; Name: Surveillance; Assigned to Arm(s): Surveillance
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Open repair | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Endovascular repair (with endograft) | Intervention Type: PROCEDURE; Name: Endovascular repair (with endograft); Assigned to Arm(s): 2 | Intervention Type: PROCEDURE; Name: Open repair; Assigned to Arm(s): 1

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Clinical Trial Comparing Surveillance and Selective Surgical Treatment for Abdominal Aortic Aneurysms Less Than 5.5 cm in Diameter Versus Early Endovascular Treatment
Brief Summary: Objective of the present study is to compare endovascular repair versus surveillance and, eventually delay treatment in patients with small abdominal aortic aneurysms (AAA), with respect to patient survival, AAA rupture and AAA related death risks.


Options:
A: Arm Label: OR; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Open Aneurysm Repair | Arm Label: EVAR; Type: EXPERIMENTAL; Interventions: Procedure: Endovascular Aneurysm Repair | Intervention Type: PROCEDURE; Name: Open Aneurysm Repair; Assigned to Arm(s): OR | Intervention Type: PROCEDURE; Name: Endovascular Aneurysm Repair; Assigned to Arm(s): EVAR
B: Arm Label: Arm 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Standard Open Repair | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Endovascular Repair | Intervention Type: PROCEDURE; Name: Endovascular Repair; Assigned to Arm(s): Arm 2 | Intervention Type: PROCEDURE; Name: Standard Open Repair; Assigned to Arm(s): Arm 1
C: Arm Label: Surveillance; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Early Endovascular Repair; Type: EXPERIMENTAL; Interventions: Device: AneuRx AAA stent graft / Talent AAA stent graft | Intervention Type: DEVICE; Name: AneuRx AAA stent graft / Talent AAA stent graft; Assigned to Arm(s): Early Endovascular Repair
D: Arm Label: EVAR; Type: EXPERIMENTAL; Interventions: Procedure: EVAR (Endovascular repair of Abdominal Aortic aneurysm) | Arm Label: Surveillance; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Surveillance | Intervention Type: PROCEDURE; Name: EVAR (Endovascular repair of Abdominal Aortic aneurysm); Assigned to Arm(s): EVAR | Intervention Type: PROCEDURE; Name: Surveillance; Assigned to Arm(s): Surveillance

Answer: D